FDA approves mosunetuzumab's subcutaneous formulation, enhancing treatment access for relapsed follicular lymphoma.
One Oncology | Strategic Alliance Partners
Latest from One Oncology
Legislative efforts aim to improve oncology medication access, addressing transportation barriers and advocating for mail delivery from cancer clinics.
Coordinating complex care plans can involve many care team members and even different pharmacists in both health system and retail environments.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists Can Implement Test-and-Treat Services in Their Practice Settings
2
Circulating Tumor Cells May Guide Use of Tarlatamab in Small Cell Lung Cancer
3
Experts: How Plozasiran Is Transforming Care for Rare Lipid Disorders
4
Q&A: Expert Warns of Public Health Risks After Childhood Vaccine Schedule Changes
5